Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

Mesenchymal stromal cells modulate gut inflammation in experimental colitis.

de Aguiar CF, Castoldi A, Andrade-Oliveira V, Ignacio A, da Cunha FF, Felizardo RJF, Bassi ÊJ, Câmara NOS, de Almeida DC.

Inflammopharmacology. 2018 Feb;26(1):251-260. doi: 10.1007/s10787-017-0404-6. Epub 2017 Oct 23.

PMID:
29063489
2.

Role of metallothionein in murine experimental colitis.

Tsuji T, Naito Y, Takagi T, Kugai M, Yoriki H, Horie R, Fukui A, Mizushima K, Hirai Y, Katada K, Kamada K, Uchiyama K, Handa O, Konishi H, Yagi N, Ichikawa H, Yanagisawa R, Suzuki JS, Takano H, Satoh M, Yoshikawa T.

Int J Mol Med. 2013 May;31(5):1037-46. doi: 10.3892/ijmm.2013.1294. Epub 2013 Mar 6.

PMID:
23467591
3.

Mesenchymal stem cells alleviate TNBS-induced colitis by modulating inflammatory and autoimmune responses.

Chen QQ, Yan L, Wang CZ, Wang WH, Shi H, Su BB, Zeng QH, Du HT, Wan J.

World J Gastroenterol. 2013 Aug 7;19(29):4702-17. doi: 10.3748/wjg.v19.i29.4702.

4.

Mast cell deficiency exacerbates inflammatory bowel symptoms in interleukin-10-deficient mice.

Zhang H, Xue Y, Wang H, Huang Y, Du M, Yang Q, Zhu MJ.

World J Gastroenterol. 2014 Jul 21;20(27):9106-15. doi: 10.3748/wjg.v20.i27.9106.

5.

Local injections of adipose-derived mesenchymal stem cells modulate inflammation and increase angiogenesis ameliorating the dystrophic phenotype in dystrophin-deficient skeletal muscle.

Pinheiro CH, de Queiroz JC, Guimarães-Ferreira L, Vitzel KF, Nachbar RT, de Sousa LG, de Souza AL Jr, Nunes MT, Curi R.

Stem Cell Rev. 2012 Jun;8(2):363-74. doi: 10.1007/s12015-011-9304-0.

PMID:
21874281
6.

Intravenous vs intraperitoneal mesenchymal stem cells administration: what is the best route for treating experimental colitis?

Gonçalves Fda C, Schneider N, Pinto FO, Meyer FS, Visioli F, Pfaffenseller B, Lopez PL, Passos EP, Cirne-Lima EO, Meurer L, Paz AH.

World J Gastroenterol. 2014 Dec 28;20(48):18228-39. doi: 10.3748/wjg.v20.i48.18228.

7.

Gut Epithelial Vitamin D Receptor Regulates Microbiota-Dependent Mucosal Inflammation by Suppressing Intestinal Epithelial Cell Apoptosis.

He L, Liu T, Shi Y, Tian F, Hu H, Deb DK, Chen Y, Bissonnette M, Li YC.

Endocrinology. 2018 Feb 1;159(2):967-979. doi: 10.1210/en.2017-00748.

PMID:
29228157
8.

Chitosan oligosaccharide as potential therapy of inflammatory bowel disease: therapeutic efficacy and possible mechanisms of action.

Yousef M, Pichyangkura R, Soodvilai S, Chatsudthipong V, Muanprasat C.

Pharmacol Res. 2012 Jul;66(1):66-79. doi: 10.1016/j.phrs.2012.03.013. Epub 2012 Mar 28.

PMID:
22475725
9.

Adipose-derived mesenchymal stromal cells induce immunomodulatory macrophages which protect from experimental colitis and sepsis.

Anderson P, Souza-Moreira L, Morell M, Caro M, O'Valle F, Gonzalez-Rey E, Delgado M.

Gut. 2013 Aug;62(8):1131-41. doi: 10.1136/gutjnl-2012-302152. Epub 2012 May 25.

PMID:
22637701
10.

Lactobacillus crispatus M206119 exacerbates murine DSS-colitis by interfering with inflammatory responses.

Zhou FX, Chen L, Liu XW, Ouyang CH, Wu XP, Wang XH, Wang CL, Lu FG.

World J Gastroenterol. 2012 May 21;18(19):2344-56. doi: 10.3748/wjg.v18.i19.2344.

11.

Enterocyte dendritic cell-specific intercellular adhesion molecule-3-grabbing non-integrin expression in inflammatory bowel disease.

Zeng JQ, Xu CD, Zhou T, Wu J, Lin K, Liu W, Wang XQ.

World J Gastroenterol. 2015 Jan 7;21(1):187-95. doi: 10.3748/wjg.v21.i1.187.

12.

Inflammation Controls Sensitivity of Human and Mouse Intestinal Epithelial Cells to Galectin-1.

Muglia CI, Gobbi RP, Smaldini P, Delgado ML, Candia M, Zanuzzi C, Sambuelli A, Rocca A, Toscano MA, Rabinovich GA, Docena GH.

J Cell Physiol. 2016 Jul;231(7):1575-85. doi: 10.1002/jcp.25249. Epub 2015 Dec 28.

PMID:
26566180
14.

Type I interferon signaling restrains IL-10R+ colonic macrophages and dendritic cells and leads to more severe Salmonella colitis.

Stefan KL, Fink A, Surana NK, Kasper DL, Dasgupta S.

PLoS One. 2017 Nov 30;12(11):e0188600. doi: 10.1371/journal.pone.0188600. eCollection 2017.

15.

Neutralization of interleukin-18 reduces severity in murine colitis and intestinal IFN-gamma and TNF-alpha production.

Siegmund B, Fantuzzi G, Rieder F, Gamboni-Robertson F, Lehr HA, Hartmann G, Dinarello CA, Endres S, Eigler A.

Am J Physiol Regul Integr Comp Physiol. 2001 Oct;281(4):R1264-73.

16.

Extracellular Vesicles Derived from Adipose Mesenchymal Stem Cells Regulate the Phenotype of Smooth Muscle Cells to Limit Intimal Hyperplasia.

Liu R, Shen H, Ma J, Sun L, Wei M.

Cardiovasc Drugs Ther. 2016 Apr;30(2):111-8. doi: 10.1007/s10557-015-6630-5.

PMID:
26650931
17.

High fat diet exacerbates dextran sulfate sodium induced colitis through disturbing mucosal dendritic cell homeostasis.

Cheng L, Jin H, Qiang Y, Wu S, Yan C, Han M, Xiao T, Yan N, An H, Zhou X, Shao Q, Xia S.

Int Immunopharmacol. 2016 Nov;40:1-10. doi: 10.1016/j.intimp.2016.08.018. Epub 2016 Aug 24.

PMID:
27567245
18.
19.

Deficiency of Nuclear Receptor Nur77 Aggravates Mouse Experimental Colitis by Increased NFκB Activity in Macrophages.

Hamers AA, van Dam L, Teixeira Duarte JM, Vos M, Marinković G, van Tiel CM, Meijer SL, van Stalborch AM, Huveneers S, Te Velde AA, de Jonge WJ, de Vries CJ.

PLoS One. 2015 Aug 4;10(8):e0133598. doi: 10.1371/journal.pone.0133598. eCollection 2015.

20.

Impact on Experimental Colitis of Vitamin D Receptor Deletion in Intestinal Epithelial or Myeloid Cells.

Leyssens C, Verlinden L, De Hertogh G, Kato S, Gysemans C, Mathieu C, Carmeliet G, Verstuyf A.

Endocrinology. 2017 Jul 1;158(7):2354-2366. doi: 10.1210/en.2017-00139.

PMID:
28472309

Supplemental Content

Support Center